Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence

Molecular Psychiatry

Volumn 5, Issue 2, 2000, Pages 189-192

  Lerman, C ^a,d   Caporaso, N E ^b   Audrain, J ^a   Main, D ^a   Boyd, N R ^c   Shields, P G ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetics; Serotonin; Smoking

Indexed keywords

NICOTINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

ADDICTION; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; FEMALE; GENOTYPE; HEREDITY; HUMAN; HUMAN EXPERIMENT; MALE; MULTIPLE REGRESSION; NEUROSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SMOKING;

EID: 0034056121     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000672     Document Type: Article

References (30)

1. 1 Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking - a study of male twins. N Engl J Med 1992; 327: 829-833.
2. 2 Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 1994; 95: 157-162.
3. 3 Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-2624.
4. 4 Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
5. 5 Gilbert DG. Personality, psychopathology, tobacco use, and individual differences in effects of nicotine. In: Baker KP, Seltzer H (eds). Smoking: Individual Differences, Psychopathology, and Emotion. Taylor & Francis: Washington, DC, 1995, pp 149-176.
6. 6 Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999; 18: 14-20.
7. 7 Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S et al. A genetic association for cigarette smoking behavior. Health Psychol 1999; 18: 7-13.
8. 8 Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
9. 9 Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF. Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 1999; 4: 93-96.
10. 10 Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2: 224-226.
11. 11 Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR et al. The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 1998; 7: 253-255.
12. 12 Hu S, Brody CL, Fisher C, Gunzerath L, Nelson ML, Sabol SZ et al. Interaction between the serotonin transporter gene and neuroticism in cigarette smoking and cessation. Mol Psychiatry 2000; 5: 181-188.
13. 13 Gelernter J, Goldman D, Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal. JAMA 1993; 269: 1673-1677.
14. 14 Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet Epidemiol 1990; 7: 3-16.
15. 15 Health AC, Neale MC, Kessler RC, Eaves LJ, Kendler KS. Evidence for genetic influences on personality from self-reports and informant ratings. J Pers Soc Psychol 1992; 63: 85-96.
16. 16 Waal-Manning HJ, de Hamel FA. Smoking habit and psychometric scores: a community study. NZ Med J 1978; 88: 188-191.
17. 17 Rausch JL, Nichinson B, Lamke C, Matloff J. Influence of negative affect on smoking cessation treatment outcome: a pilot study. Br J Addict 1990; 85: 929-933.
18. 18 Audrain J, Lerman C, Gomez-Caminero A, Boyd NR, Orleans CT. The role of trait anxiety in nicotine dependence. J Appl Biobehav Res 1998; 3: 29-42.
19. 19 Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ III, van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high-and low-anxiety smokers. J Clin Psychopharmacol 1995; 15: 182-191.
20. 20 Niaura R, Goldstein M, Spring B, Keuthen N, Kristeller J, DePue J. Fluoxetine for smoking cessation: a multicenter randomized double blind dose response study. Paper presented at the 18th Annual Meeting of the Society of Behavioral Medicine, San Francisco, CA, 1997.
21. 21 Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998; 3: 508-511.
22. 22 Eysenck HJ, Eysenck SBG. Manual of the Eysenck Personality Inventory. Hodder and Stoughton: London, 1964.
23. 23 Meites K, Lovallo W, Pishkin V. A comparison of four scales for anxiety, depression, and neuroticism. J Clin Psychol 1980; 36: 427-430.
24. 24 Horn D, Waingrow S. In: Behavior and Attitudes Questionnaire. National Clearinghouse for Smoking and Health: Bethesda, MD, 1966.
25. 25 Joffe R, Lowe MR, Fisher EB Jr. A validity test of the reasons for smoking scale. Addict Behav 1981; 6: 41-45.
26. 20 Tate JC, Stanton AL. Assessment of the validity of the Reasons for Smoking scale. Addict Behav 1990; 15: 129-135.
27. 27 Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994; 87: 1086-1093.
28. 28 Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991; 86: 1119-1127.
29. 29 Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerström tolerance questionnaire and the Fagerström test for nicotine dependence. Addict Behav 1994; 19: 33-39.
30. 30 Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J 1990; 69: 763-765.